A comparison of the lymphoproliferative capacity of pokeweed mitogen (PWM) and phytohaemagglutinin (PHA) in CCR-5 wild-type and heterozygous HIV-infected and uninfected subjects

International Journal of STD and AIDS

Volumn 13, Issue 10, 2002, Pages 691-697

  Barabas E ^a,b   Kemeny B ^a   Gonzalez R ^b   Varkonyi V ^b   Nagy, K ^a   Horvath A ^a  

^a Natl Inst of Dermato Venereology   (Hungary)

^b ROYAL SOCIETY OF MEDICINE   (United Kingdom)

Author keywords

CCR 5 delta 32 heterozygosity; HIV 1; Lectins; Whole blood culture

Indexed keywords

CHEMOKINE RECEPTOR CCR5; LECTIN; LEUKOAGGLUTININ; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; VIRUS GLYCOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0036788943     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646202760326444     Document Type: Article

References (31)

1. Samson M, Libert J, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5
2. Eugen-Olsen J, Iversen AKN, Garred P, et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997;11:305-10
3. Magierowska M, Theodorou I, Debré P, et al. Combined genotypes of CCR-5, CCR2, SDF1, and HLA genes can predict the long-term non progressor status in human immunodeficiency virus-1-infected individuals. Blood 1999; 93:936-41
4. Petersen DC, Kotze MJ, Zeier MD, et al. Novel mutations identified using a comprehensive CCR5-denaturing gradient gel electrophoresis assay. AIDS 2001;15:171-7
5. Dean M, Carrington M, Winkler Ch, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62
6. Meyer L, Magierowska M, Hubert JB, et al. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression. Relationship with viral load. The SEROCO study group. AIDS 1997;11:F73-78
7. Lockett SF, Alonso A, Wyld R, et al. Effect of chemokine receptor mutation on heterosexual human immunodeficiency virus transmission. J Infect Dis 1999;180:614-21
8. Huang Y, Paxton WA, Wolinsky SM, et al. The role of mutant CCR-5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-3
9. Jagers E, De Brabander M, Baisier A, et al. A simple and rapid flow cytometric method to measure lymphocyte activation in HIV+ subjects. Diminished response to pokeweed mitogen in early disease. Anal Cell Pathol 1995;8:345-55
10. Clerici M, Shearer GM. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-11
11. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: New insights. Immunol Today 1994;15:575-81
12. Gonzálex-Cabello R, Gergely P. Lectin-induced lymphocyte transformation in whole blood (in Hungarian). Kisérl Orvostud 1979;31:399-404
13. González-Cabello R, Speisky H, Bannach R, Valenzuela A, Fehér J, Gergely P. Effects of boldine on cellular immune functions in vitro. J Invest Allerg Clin 1994;4:139-45
14. González-Cabello R, Barabás É, Kemény B, et al. Whole blood lymphocyte blast transformation in HIV+ donors (in Hungarian). Dermatol Szemle 1997;73:21-4
15. Sambrok J, Fritsch EF, Maniatis T. (Eds). Molecular Cloning 1-3. 2nd edn. New York: Cold Spring Harbor Laboratory, 1989
16. StarSoft, Inc. STATISTICA for Windows. Tulsa, OK, USA, 1997
17. Stewart GJ, Ashton LJ, Biti RA, et al. Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian long-term non-progressor study group. AIDS 1997;11:1833-8
18. Kemény B, Nagy K, Horváth A. DNA polymorphism of HIV coreceptor CCR-5 gene in HIV infected patients and in general population. J Invest Dermatol 1998;110:617
19. Kemény B, Nagy K, Barabás É, Horváth A. Chemokine and chemokine receptor gene polymorphism in central European HIV-infected patients. European Conference on Experimental AIDS Research 2000; p.56
20. Bratt G, Leandersson AC, Albert J, Sandstrom E, Wahren B. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1 infected individuals. AIDS 1998;12:729-36
21. Bratt G, Karlsson A, Leandersson AC, Albert J, Wahren B, Sandstrom E. Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment. AIDS 1998;12:193-202
22. Gallart T, de la Fuente A, Barceló JJ, Alberola-Ila J, Lozano F. Desialylation of T-lymphocytes overcomes the monocyte dependency of pokeweed mitogen-induced T-cell activation. Immunology 1997;90:57-65
23. Cicala C, Arthos J, Rubbert A, et al. HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4+ cells. Proc Natl Acad Sci USA 2000;97:1178-83
24. Wang J, Meijers R, Ziong Y, et al. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci USA 2001;98:10799-10804
25. Davis CB, Dikic I, Unutmaz D, et al. Signal transduction due to HIV-1 envelope interaction with chemokine receptors CXCR4 or CCR-5. J Exp Med 1997;186:1793-8
26. Cicala C, Arthos J, Ruiz M, et al. Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ cells by macrophage-tropic HIV envelope. J Immunol 1999;163:420-26
27. Lakshmi Tamma SM, Chirmule N, McCloskey TW, Oyaizu N, Kalyanaraman VS, Pahwa S. Signals transduced through the CD4 molecule interfere with TCR/CD3-mediated fas activation leading to T cell anergy/apoptosis. Clin Immunol Immun 1997;85:195-201
28. Patke CL, Shearer WT. gp120- and TNF-alpha-induced modulation of human B cell function: proliferation, cyclic AMP generation, Ig production, and B-cell receptor. J Allergy Clin Immunol 2000;105:975-82
29. Barabás É, González R, Nagy K, Várkonyi V, Horváth A. No change on impaired cellular immune response of HIV-negative homosexuals after 15 years of HIV epidemic in Eastern/Central European region. J Invest Allergol Clin Immunol 2001;11:172-5
30. Hollán Zs, Füst G, Nagy K, et al. Immunological alterations in anti-HTLV-III negative haemophiliacs and homosexual men in Hungary. Immunol Letters 1985;11:305-10
31. Modiano JF, Mayor J, Ball C, et al. Quantitative and qualitative signals determine T-cell cycle entry and progression. Cell Immunol 1999;197:19-29